[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100501059":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":22,"responsibleParty":40,"collaborators":10,"id":43,"slug":10,"hasResults":44,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":44,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":54,"studyType":55,"phases":10,"briefSummary":56,"conditions":57,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Western Sydney Local Health District","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patient with Gastrointestinal neoplasm",null,"Pt referred for resection of gastrointestinal neoplasm. Observational data collected from endoscopic submucosal dissection (ESD), submucosal-tunnelling endoscopic resection (STER) or endoscopic full-thickness resection (EFTR) of gastrointestinal neoplasm",[13],{"name":14,"affiliation":15,"role":16},"Michael Bourke","WSLHD","PRINCIPAL_INVESTIGATOR",[18],{"name":14,"role":19,"phone":20,"phoneExt":10,"email":21},"CONTACT","02 8890 5555","michael@citywestgastro.com.au",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Westmead Hospital","RECRUITING","Sydney","New South Wales","2145","Australia",{"type":31,"coordinates":32},"Point",[33,34],151.20732,-33.86785,{"lat":34,"lon":33},[37],{"name":38,"role":19,"phone":10,"phoneExt":10,"email":39},"Clarence Kerrison","clarence.kerrison@health.nsw.gov.au",{"type":16,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Professor Michael Bourke","Director of Endoscopy","100501059",false,"NCT05804331","The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study","ANZ UGI","Inclusion Criteria:\n\n* UGI neoplastic lesions \\> 10mm\n\n  * Lesions for ESD limited to the mucosal and\u002For submucosal layer OR\n  * Lesions for EFTR limited to the muscularis propria layer OR\n  * Lesions for STER limited to the submucosal and\u002For muscularis propria layer\n* Aged 18 years or older\n\nExclusion Criteria:\n\n* Age less than 18\n* Unable to give informed consent\n* Pregnant or lactating patients\n* Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally","ALL","18 Years",{"count":52,"type":53},500,"ESTIMATED","3 Years","OBSERVATIONAL","To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions",[58,59,60,61,62,63,64,65,66],"Cancer of Stomach","Oesophageal Cancer","Gastric Cancer","Gastric Adenocarcinoma","GI Cancer","GIST","Neuroendocrine Tumors","Gastric Neoplasm","Esophageal Neoplasms","2025-03-25",{"date":69,"type":70},"2025-03-27","ACTUAL",{"date":72,"type":70},"2023-03-14",{"date":74,"type":53},"2028-09-14",{"name":5,"class":6},1]